SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 723.24-2.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Miljenko Zuanic4/1/2020 11:39:13 AM
1 Recommendation

Recommended By
DewDiligence_on_SI

   of 3559
 
Interesting article on potentially *negative* outcome for the Ab-RBD spike protein, neutralizing or not!

Also, keep in mind that Abs, by binding to spike-protein, can change RBD-conformation and actually *activate* protein tertiary structure, promoting entry into cells!

jvi.asm.org

PS: Demonstrate how important is to study Abs in live-viral animal model before start clinical trial!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News